KMTS · NASDAQ
Kestra Medical Technologies, Ltd.
$30.61 +0.02 (+0.05%)
Company overview
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company develops and commercializes its Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its Cardiac Recovery System platform is the ASSURE WCD, a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA).
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Exchange
- NASDAQ
- Market cap
- $1.8B
- Employees
- 300
- Headquarters
- Kirkland, WA
- Website
- kestramedical.com
- CEO
- Brian Webster
- Listed
- March 6, 2025
- P/E
- -7.73
- Dividend yield
- 0.00%
Company financials
- Revenue
- $83.7M
- Gross profit
- $40.8M
- Operating income
- -$144M
- EBITDA
- -$128M
- Net income
- -$145M
- EPS
- -$3.96
- Total assets
- $379M
- Total debt
- $4.3M
- Gross margin
- 48.75%
- Net margin
- -172.99%
- Earnings yield
- -12.94%
KMTS
1D
NASDAQ
O30.48H30.86L30.14C30.60+0.72 (+2.43%)Vol95.13K